Disruption of prion protein–HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival
Glioblastomas (GBMs) are resistant to current therapy protocols and identification of molecules that target these tumors is crucial. Interaction of secreted heat-shock protein 70 (Hsp70)–Hsp90-organizing protein (HOP) with cellular prion protein (PrP C ) triggers a large number of trophic effects in...
Saved in:
Published in: | Oncogene Vol. 34; no. 25; pp. 3305 - 3314 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
Nature Publishing Group UK
18-06-2015
Nature Publishing Group |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Glioblastomas (GBMs) are resistant to current therapy protocols and identification of molecules that target these tumors is crucial. Interaction of secreted heat-shock protein 70 (Hsp70)–Hsp90-organizing protein (HOP) with cellular prion protein (PrP
C
) triggers a large number of trophic effects in the nervous system. We found that both PrP
C
and HOP are highly expressed in human GBM samples relative to non-tumoral tissue or astrocytoma grades I–III. High levels of PrP
C
and HOP were associated with greater GBM proliferation and lower patient survival. HOP–PrP
C
binding increased GBM proliferation
in vitro
via phosphatidylinositide 3-kinase and extracellular-signal-regulated kinase pathways, and a HOP peptide mimicking the PrP
C
binding site (HOP
230–245
) abrogates this effect. PrP
C
knockdown impaired tumor growth and increased survival of mice with tumors. In mice, intratumor delivery of HOP
230–245
peptide impaired proliferation and promoted apoptosis of GBM cells. In addition, treatment with HOP
230–245
peptide inhibited tumor growth, maintained cognitive performance and improved survival. Thus, together, the present results indicate that interfering with PrP
C
–HOP engagement is a promising approach for GBM therapy. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/onc.2014.261 |